Gland Pharma shareholder resolutions pass with strong support

Hyderabad-based Gland Pharma (BSE:GLAND) announced the successful passage of two special resolutions related to its employee stock option scheme (ESOP) following a postal ballot. The resolutions were approved with over 90% of votes cast in favor, as per a scrutineer's report dated March 31, 2025. The first resolution concerned the approval of the "Gland Pharma Employee Stock Option Scheme 2025," while the second authorized the grant of stock options to employees of the company's subsidiaries under the same scheme. The company confirmed adherence to SEBI regulations and MCA circulars during the voting process. RVR & Associates served as the scrutineer for the postal ballot.